How close are we to individualized medicine for Parkinson’s disease?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How close are we to individualized medicine for Parkinson’s disease?
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 16, Issue 7, Pages 815-830
Publisher
Informa UK Limited
Online
2016-04-23
DOI
10.1080/14737175.2016.1182021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic Analysis of Candidate Genes for Alzheimer's Disease in a French, Genome-Wide Association Study
- (2017) Geoffroy Laumet et al. JOURNAL OF ALZHEIMERS DISEASE
- Precision Medicine
- (2016) M Pacanowski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson’s disease patients
- (2015) Shahidee Zainal Abidin et al. BMC Neurology
- Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson’s disease
- (2015) Caroline Moreau et al. BRAIN
- Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?
- (2015) JA Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Neuroprotection in Parkinson's disease: a difficult challenge
- (2015) Fabrizio Stocchi LANCET NEUROLOGY
- BDNF polymorphism associates with decline in set shifting in Parkinson's disease
- (2015) Nicolien M. van der Kolk et al. NEUROBIOLOGY OF AGING
- Time to change the blind men and the elephant approach to Parkinson disease?
- (2015) Brad A. Racette et al. NEUROLOGY
- Cognitive, Neuropsychiatric, and Motor Features Associated With Apolipoprotein E ∊4 Allele in a Sample of Bulgarian Patients With Late-Onset Parkinson’s Disease
- (2014) Radka Pavlova et al. American Journal of Alzheimers Disease and Other Dementias
- Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study
- (2014) Cristina Nombela et al. BRAIN
- Sequence Variants in SLC6A3, DRD2, and BDNF Genes and Time to Levodopa-Induced Dyskinesias in Parkinson’s Disease
- (2014) Natalie Kaplan et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
- (2014) P. J. Garcia-Ruiz et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease
- (2014) T. Celeste Napier et al. MOVEMENT DISORDERS
- Clinical spectrum of impulse control disorders in Parkinson's disease
- (2014) Daniel Weintraub et al. MOVEMENT DISORDERS
- The neurobiological basis of cognitive impairment in Parkinson's disease
- (2014) Glenda M. Halliday et al. MOVEMENT DISORDERS
- GBA-associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study
- (2014) Kathrin Brockmann et al. MOVEMENT DISORDERS
- BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease
- (2014) Monika Białecka et al. NEUROSCIENCE LETTERS
- Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population
- (2014) Hongying Hao et al. PARKINSONISM & RELATED DISORDERS
- Catechol-O-methyltransferase Val158Met polymorphism: Modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease
- (2014) Hui Wu et al. PARKINSONISM & RELATED DISORDERS
- APOE,MAPT, andSNCAGenes and Cognitive Performance in Parkinson Disease
- (2014) Ignacio F. Mata et al. JAMA Neurology
- Predicting Cognitive Decline in Parkinson’s Disease: Can We Ask the Genes?
- (2014) Fabiola De Marchi et al. Frontiers in Neurology
- Glucocerebrosidase mutations influence the natural history of Parkinson’s disease in a community-based incident cohort
- (2013) Sophie E. Winder-Rhodes et al. BRAIN
- No Association between Brain-Derived Neurotrophic Factor G196A Polymorphism and Clinical Features of Parkinson's Disease
- (2013) Marina Svetel et al. EUROPEAN NEUROLOGY
- Original article Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson’s disease in an Iranian population
- (2013) Anahita Torkaman-Boutorabi et al. FOLIA NEUROPATHOLOGICA
- Polymorphisms in the dopamine transporter gene are associated with visual hallucinations and levodopa equivalent dose in Brazilians with Parkinson's disease
- (2013) Artur F Schumacher-Schuh et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cry1 and Tef gene polymorphisms are associated with major depressive disorder in the Chinese population
- (2013) Ping Hua et al. JOURNAL OF AFFECTIVE DISORDERS
- Screening for impulse control symptoms in patients with de novo Parkinson disease: A case-control study
- (2013) D. Weintraub et al. NEUROLOGY
- Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies
- (2013) Ariana P. Gatt et al. NEUROSCIENCE LETTERS
- Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs WithoutGBAMutations
- (2013) Lama M. Chahine et al. JAMA Neurology
- Neuropathologic substrates of Parkinson disease dementia
- (2012) David J. Irwin et al. ANNALS OF NEUROLOGY
- Circadian and sleep disorders in Parkinson's disease
- (2012) Aleksandar Videnovic et al. EXPERIMENTAL NEUROLOGY
- The six gaps in the search of neuroprotection for Parkinson’s disease
- (2012) Alberto J Espay et al. Expert Review of Neurotherapeutics
- Serotonergic involvement in levodopa-induced dyskinesias in Parkinson’s disease
- (2012) Perdita A. Cheshire et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
- (2012) Per Svenningsson et al. LANCET NEUROLOGY
- Association of Tef polymorphism with depression in Parkinson disease
- (2012) Ping Hua et al. MOVEMENT DISORDERS
- Trial designs used to study neuroprotective therapy in Parkinson's disease
- (2012) Anthony E. Lang et al. MOVEMENT DISORDERS
- Genetic influences on cognitive decline in Parkinson's disease
- (2012) James F. Morley et al. MOVEMENT DISORDERS
- Impulse Control and Related Disorders in Parkinsons Disease
- (2012) Daniel Weintraub et al. Neurodegenerative Diseases
- Cognitive performance of GBA mutation carriers with early-onset PD: The CORE-PD study
- (2012) R. N. Alcalay et al. NEUROLOGY
- DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson’s disease patients
- (2012) Mariana Rieck et al. PHARMACOGENOMICS
- Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson's Disease
- (2012) O. Cooper et al. Science Translational Medicine
- Converging evidence implicates the dopamine D3 receptor gene in vulnerability to schizophrenia
- (2011) Fuquan Zhang et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Therapies for dopaminergic-induced dyskinesias in parkinson disease
- (2011) Mildred D. Gottwald et al. ANNALS OF NEUROLOGY
- Dementia Risk in Parkinson Disease
- (2011) Núria Setó-Salvia et al. ARCHIVES OF NEUROLOGY
- Pharmacological treatment and the prospect of pharmacogenetics in Parkinson’s disease
- (2011) K. Kalinderi et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1)
- (2011) Johanne H. Somme et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Sleep disorders in Parkinson's disease: Many causes, few therapeutic options
- (2011) Nico J. Diederich et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease
- (2011) Lonneke M.L. de Lau et al. MOVEMENT DISORDERS
- Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease
- (2011) Stewart A. Factor et al. MOVEMENT DISORDERS
- The motor phenotype of Parkinson's disease in relation to age at onset
- (2011) Mirdhu M. Wickremaratchi et al. MOVEMENT DISORDERS
- DLB and PDD: a role for mutations in dementia and Parkinson disease genes?
- (2011) Bram Meeus et al. NEUROBIOLOGY OF AGING
- GBA-associated PD presents with nonmotor characteristics
- (2011) K. Brockmann et al. NEUROLOGY
- Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson’s disease
- (2011) Jee-Young Lee et al. PARKINSONISM & RELATED DISORDERS
- Role of genetic polymorphisms of the dopaminergic system in Parkinson’s disease patients with impulse control disorders
- (2011) Annamaria Vallelunga et al. PARKINSONISM & RELATED DISORDERS
- TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons
- (2011) M. Baydyuk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson’s disease
- (2010) L. Gao et al. ACTA NEUROLOGICA SCANDINAVICA
- The role of apolipoprotein E polymorphisms in levodopa-induced dyskinesia
- (2010) I. Molchadski et al. ACTA NEUROLOGICA SCANDINAVICA
- Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia
- (2010) Daniella Rylander et al. ANNALS OF NEUROLOGY
- The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial
- (2010) Jean-Christophe Corvol et al. ANNALS OF NEUROLOGY
- Impulse Control Disorders in Parkinson Disease
- (2010) Daniel Weintraub et al. ARCHIVES OF NEUROLOGY
- Relationships between age and late progression of Parkinson's disease: a clinico-pathological study
- (2010) P. A. Kempster et al. BRAIN
- SIRT1 gene is associated with major depressive disorder in the Japanese population
- (2010) Taro Kishi et al. JOURNAL OF AFFECTIVE DISORDERS
- Two Parkinson's disease patients with α-synuclein gene duplication and rapid cognitive decline
- (2010) Chae Won Shin et al. MOVEMENT DISORDERS
- Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease
- (2010) Jeroen Hoogland et al. MOVEMENT DISORDERS
- Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease
- (2010) Jee-Young Lee et al. MOVEMENT DISORDERS
- Differential Association of Circadian Genes with Mood Disorders: CRY1 and NPAS2 are Associated with Unipolar Major Depression and CLOCK and VIP with Bipolar Disorder
- (2010) Virginia Soria et al. NEUROPSYCHOPHARMACOLOGY
- The Path to Personalized Medicine
- (2010) Margaret A. Hamburg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein E epsilon 4 allele is not associated with age at onset or MMSE of Parkinson’s disease in a Korean study
- (2010) Hye Guk Ryu et al. PARKINSONISM & RELATED DISORDERS
- CRY2 Is Associated with Depression
- (2010) Catharina Lavebratt et al. PLoS One
- Genetics of dopamine receptors and drug addiction: a comprehensive review
- (2009) Bernard Le Foll et al. BEHAVIOURAL PHARMACOLOGY
- Haplotype frequencies at the DRD2 locus in populations of the East European Plain
- (2009) Olga V Flegontova et al. BMC GENETICS
- The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
- (2009) Caroline H. Williams-Gray et al. BRAIN
- Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
- (2009) Juliane Neumann et al. BRAIN
- Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson’s disease patients
- (2009) Ying-Zi Liu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson’s disease
- (2009) F. R. Guerini et al. EUROPEAN JOURNAL OF NEUROLOGY
- APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study
- (2009) Martin Wilhelm Kurz et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease
- (2009) C. H. Williams-Gray et al. JOURNAL OF NEUROLOGY
- Motor complications in patients form the German Competence Network on Parkinson's disease and theDRD3 Ser9Glypolymorphism
- (2009) Sebastian Paus et al. MOVEMENT DISORDERS
- Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease
- (2009) Jee-Young Lee et al. MOVEMENT DISORDERS
- No association between polymorphism of serotonin transporter gene and depression in Parkinson's disease in Chinese
- (2009) Jing-Lin Zhang et al. NEUROSCIENCE LETTERS
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease
- (2009) Jee-Young Lee et al. PARKINSONISM & RELATED DISORDERS
- Genomic investigation of α-synuclein multiplication and parkinsonism
- (2008) Owen A. Ross et al. ANNALS OF NEUROLOGY
- Targets for neuroprotection in Parkinson's disease
- (2008) Talene A. Yacoubian et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Pharmacogenetics and the serotonin transporter in late-life depression
- (2008) Philip Gerretsen et al. Expert Opinion on Drug Metabolism & Toxicology
- BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease
- (2008) T Foltynie et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Genetic polymorphism of Angiotensin-Converting Enzyme is not associated with the development of Parkinson's disease and of l-dopa-induced adverse effects
- (2008) Esterina Pascale et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- TheDRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease
- (2008) Sebastian Paus et al. MOVEMENT DISORDERS
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease
- (2008) Nadeeka N.W. Dissanayaka et al. MOVEMENT DISORDERS
- Lack of association of APOE and tau polymorphisms with dementia in Parkinson’s disease
- (2008) Mario Ezquerra et al. NEUROSCIENCE LETTERS
- The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinsonʼs disease, levodopa treatment response, and complications
- (2008) Monika Bialecka et al. Pharmacogenetics and Genomics
- Variation in dopamine genes influences responsivity of the human reward system
- (2008) J.-C. Dreher et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alpha-synuclein promoter haplotypes and dementia in Parkinson's Disease
- (2007) E.V. De Marco et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- The relationship between impulsivity and impulse control disorders in Parkinson's disease
- (2007) Ioannis U. Isaias et al. MOVEMENT DISORDERS
- Predictors of impulsivity and reward seeking behavior with dopamine agonists
- (2007) William G. Ondo et al. PARKINSONISM & RELATED DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search